Publication date: Sep 27, 2019
To reverse the opioid crisis that continues to grip the nation, the National Institutes of Health has awarded $945 million in total fiscal year 2019 funding for grants, contracts and cooperative agreements across 41 states through the Helping to End Addiction Long-term Initiative or NIH HEAL Initiative.
The trans-NIH research effort aims to improve treatments for chronic pain, curb the rates of opioid use disorder (OUD) and overdose, and achieve long-term recovery from opioid addiction.
The NIH HEAL Initiative is leveraging expertise from almost every NIH institute and center to approach the crisis from all angles and disciplines, and across the full spectrum of research from basic to implementation science in the areas of: “It’s clear that a multi-pronged scientific approach is needed to reduce the risks of opioids, accelerate development of effective non-opioid therapies for pain and provide more flexible and effective options for treating addiction to opioids,” said NIH Director Francis S. Collins, M. D., Ph. D., who launched the initiative in early 2018.
Scientific solution: Research through the NIH HEAL Initiative will inform treatment guidelines for clinical care of infants who are exposed to opioids in the womb.
“We need to ensure that people with chronic pain have effective treatment options that don’t expose them to the risk of opioids,” said Rebecca G. Baker, Ph. D., director, NIH HEAL Initiative.
|disease||MESH||low back pain|
- Opioid crackdown forces pain patients to taper off drugs they say they need
- The Opioid Crisis and the Future of Addiction and Pain Therapeutics.